Product Information
VARDENAFIL HCL 5 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $7.0998 per EA under NDC 70710106903. Its NADAC has been published 111 times since Aug 21, 2024.
FDA first approved this application on Oct 31, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
70710106903
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
3/18/2026
Active Ingredients
VARDENAFIL HYDROCHLORIDE TRIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA208960FDA Approved
10/31/2018
TE Code
AB
On Market Since
11/1/2018
Pharmacological Classes
Price Statistics
The NADAC for VARDENAFIL HCL 5 MG TABLET has been published 111 times since Aug 21, 2024, and over the history we have for it it has risen 106.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $7.0998 per EA |
|---|---|
| All-time high | $7.1016 (Mar 11, 2026) |
| All-time low | $2.7518 (Apr 23, 2025) |
| 52-week high | $7.1016 |
| 52-week low | $4.7805 |
| Median price | $4.7542 |
| Average price | $4.8431 |
| Largest weekly change | +72.8% (Aug 20, 2025) |
| Weeks tracked | 111 |
| Tracking since | Aug 21, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the VARDENAFIL market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Zydus Pharmaceuticals (USA) Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
VARDENAFIL market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Phosphodiesterase 5 Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VARDENAFIL HCL 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VARDENAFIL HCL 5 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $7.0998 per EA (NDC 70710106903), effective Sep 30, 2026.
How has the price of VARDENAFIL HCL 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for VARDENAFIL HCL 5 MG TABLET has risen 106.1%. It has been tracked across 111 weekly CMS publications since Aug 21, 2024.
What are the highest and lowest recorded NADAC prices for VARDENAFIL HCL 5 MG TABLET?
Since Aug 21, 2024, the NADAC for VARDENAFIL HCL 5 MG TABLET has ranged from a low of $2.7518 (Apr 23, 2025) to a high of $7.1016 (Mar 11, 2026), with a median of $4.7542 per EA.
Are there cheaper alternatives to VARDENAFIL HCL 5 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of VARDENAFIL HCL 5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures VARDENAFIL HCL 5 MG TABLET?
VARDENAFIL HCL 5 MG TABLET (NDC 70710106903) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.